Macro Biologics’ innovative technology platform creates synthetic biological polymers (macro biologics) for breakthrough therapeutics, next-generation medical devices, and advanced biomaterials safe for the environment.
Location: United States, California, Carlsbad
Employees: 1-10
Investors 1
| Date | Name | Website |
| 19.05.2023 | CARB-X | carb-x.org |
Mentions in press and media 4
| Date | Title | Description |
| 18.06.2026 | Macro Biologics IND Accepted by FDA for Amicidin-α Surgical Gel’s Phase 1 Clinical Trial | Amicidin-α Surgical Gel is designed to protect the vulnerable tissues of surgical and traumatic wounds and reduce the risk of infection Our top priority is to create a new generation of advanced biomaterials that can protect at-risk patient... |
| 01.07.2025 | Macro Biologics and Curapath Expand Strategic Partnership to Manufacture Advanced Biomaterials for Healthcare and Beyond | VALENCIA, COMUNIDAD VALENCIANA, SPAIN, July 1, 2025 /EINPresswire.com/ -- Macro Biologics, Inc. , a US-based company (Carlsbad, Carlifornia) at the intersection of materials science and biotechnology, develops innovative products for health... |
| 03.09.2024 | Amicrobe, Inc. Announces Name Change to Macro Biologics, Inc. | Name change marks a new phase in corporate development Our new name speaks to our purpose – to use our macro biologics technology platform to help with some of the world’s biggest problems” — Michael Bevilacqua, MD, PhDCARLSBAD, CALIFORNIA,... |
| 03.09.2024 | Macro Biologics, Inc. to Present 'Amicidins - Guarding the gateways to sepsis' at World AMR Congress 2024 | Infection is a progression – best stopped early This gathering of dedicated, like-minded people in Philadelphia offers an important opportunity to exchange scientific, medical, and operational strategies to address this enormous challenge.”... |